By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A consortium of researchers in Europe have received a grant of nearly €6 million ($8.4 million) from the EU to fund studies of two breast cancer types that are difficult to treat and amount to one quarter of all breast cancer cases: invasive lobular carcinoma and triple-negative breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.